Search - tctmd.com

Displaying 201 - 217 of 217

Sort: Relevancy | Date

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Yael L. Maxwell

March 15, 2012

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn

April 21, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Daily News

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Early GPI More Effective When Paired with Upstream Clopidogrel in NSTE ACS

Caitlin E. Cox

February 10, 2011

Advertisement

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Nonaccess Site Bleeding After PCI Strongly Tied to Long-term Mortality

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Early GPI More Effective When Paired with Upstream Clopidogrel in NSTE ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content